Generating validated knockout cell lines demands both precise genome editing and reliable single-cell isolation. This session presents case study data on CRISPR/Cas9 knockout generation across commercially available and immortalized primary renal epithelial cells and iPSCs, with a focus on workflow strategies that improve clonal outgrowth, viability, and throughput.
Speakers will share experimental results from the optimization and validation of ß2M knockout iPSC clones, including protein-level confirmation of successful editing. They will demonstrate how integrating advanced culture reagents with microfluidic sorting technology can reduce the time and labor associated with clonal cell line development.
Join this webinar to: